Lataa...

Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells

Acute myeloid leukemia (AML) is an aggressive malignancy lacking targeted therapy due to shared molecular and transcriptional circuits as well as phenotypic markers with normal hematopoietic stem cells (HSCs). Identifying leukemia specific markers expressed on AML or AML subtypes for therapeutic tar...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer
Päätekijät: Salman, Huda, Pinz, Kevin G., Wada, Masayuki, Shuai, Xiao, Yan, Lulu E., Petrov, Jessica C., Ma, Yupo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6691696/
https://ncbi.nlm.nih.gov/pubmed/31413761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.28952
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!